Sunday, February 21, 2021 11:24:36 AM
The Phase 3 DISRUPT trial of Exebacase has 41 open trial Sites enrolling (Hospitals) in the U.S. currently. In the Phase 2 trial of Exebacase, there were 78 sites throughout the world of which 31 were in the U.S.
I realize that DISRUPT trial design involves only U.S. sites and there is a distinct advantage of this I e uniform standard of care. I just like that they have more sites open in the US which bodes well for enrollment to accelerate.
Having said this, management's silence likely means things are going slower cause of the pandemic. Hoping for some new guidance soon.
FEATURED North Bay Resources Announces Federal (MSHA) Approval of Mt. Vernon Gold Mine Operational Plan and Commencement of Production, Sierra County, California • Oct 21, 2024 9:00 AM
Hydromer, Inc. Announces the Restructuring and Formation of World-Class Research and Development Division to Drive Innovation and New Product Development • HYDI • Oct 21, 2024 9:00 AM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM